Evidence map›Paper›PMID 30169540›Full record

ArticlePloS one2018

Genomics-guided discovery and structure identification of cyclic lipopeptides from the Bacillus siamensis JFL15.

Ben-Hong Xu, Ya-Qin Lu, Zhi-Wei Ye, Qian-Wang Zheng, Tao Wei, Jun-Fang Lin, Li-Qiong Guo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Bacillibactin, a PotentialInternational journal of molecular sciences · 2025
    Article
  5. Antimicrobial Activity ofInternational journal of molecular sciences · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Comparative Study ofFrontiers in cellular and infection microbiology · 2022
    Article
  15. Review
  16. Article
  17. Antifungal Activity of Cyclic Tetrapeptide fromPathogens (Basel, Switzerland) · 2021
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ben-Hong XuCollege of Food Science and Institute of Food Biotechnology, South China Agricultural University, Guangzhou, China.
Ya-Qin LuCollege of Food Science and Institute of Food Biotechnology, South China Agricultural University, Guangzhou, China.
Zhi-Wei YeCollege of Food Science and Institute of Food Biotechnology, South China Agricultural University, Guangzhou, China.
Qian-Wang ZhengCollege of Food Science and Institute of Food Biotechnology, South China Agricultural University, Guangzhou, China.
Tao WeiCollege of Food Science and Institute of Food Biotechnology, South China Agricultural University, Guangzhou, China.
Jun-Fang LinCollege of Food Science and Institute of Food Biotechnology, South China Agricultural University, Guangzhou, China.ORCID 0000-0002-2981-5188
Li-Qiong GuoCollege of Food Science and Institute of Food Biotechnology, South China Agricultural University, Guangzhou, China.
South China Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this research, a strain with broad-spectrum antimicrobial activities was isolated from the gastrointestinal tract of hairtail (Trichiurus haumela) and identified as Bacillus siamensis JFL15 through morphological, 16S rRNA, and average nucleotide identity analyses. The genome of B. siamensis JFL15 was sequenced, and three gene clusters involved in the biosynthesis of surfactin (srf), bacillibactin (dhb), and fengycin (fen) were predicted through antiSMASH analysis. The combined genomics-metabolics profiling of the strain revealed 20 active compounds, which belong to four main types of cyclic lipopeptides produced by Bacillus species: bacillibactin, iturin, fengycin, and surfactin. Among these lipopeptides, two high-purity antifungal components, namely, components b and c, were successfully identified as iturin A and bacillomycin F. The minimum inhibitory concentrations (MICs) of iturin A for Magnapothe grisea, Rhizoctorzia solani, and Colletotrichum gloeosporioides were 125.00, 62.50, and 125.00 μg/ml, respectively, whereas the MICs of bacillomycin F for these three organisms were 62.50, 31.25, and 62.50 μg/ml, respectively. The mechanism of bacillomycin F and iturin A against M. grisea was also investigated. Scanning electron microscopy (SEM) indicated that the surface of the hypha treated with iturin A or bacillomycin F became sunk, lumpy, and wrinkled. The diversity of the identified and predicted compounds from B. siamensis JFL15 suggested that this strain might be a promising biocontrol agent for an effective and environmentally friendly control of pathogenic microorganisms. To the best of our knowledge, this study is the first to describe cyclic lipopeptides purified and identified from B. siamensis.

Indexed as

Antifungal AgentsBacillusBacterial ProteinsColletotrichumGenome, BacterialGenomicsHyphaeLipopeptidesMagnaportheMicrobial Sensitivity TestsPhylogenyRhizoctoniaAntifungal AgentsBacterial ProteinsLipopeptides

Identifiers

PMID30169540
PMCPMC6118384
OpenAlexW2889412335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.